Improving inhaler technique in asthma/COPD by mHealth: a Belgian RCT

L. Lahousse, Anna Vanoverschelde
{"title":"Improving inhaler technique in asthma/COPD by mHealth: a Belgian RCT","authors":"L. Lahousse, Anna Vanoverschelde","doi":"10.1183/13993003.congress-2019.pa2235","DOIUrl":null,"url":null,"abstract":"Introduction: Despite inhalation medication being the main treatment of asthma/COPD patients, only one third of patients demonstrates a correct inhaler technique. While pharmaceutical care has shown to effectively improve inhaler technique, the integration of the MyPuff app to support continued patient education at home has not been evaluated. Aim: To investigate improvement in inhaler technique by integrating a mHealth app compared to standard information leaflets into pharmaceutical care provided to patients with asthma/COPD. Methods: This 3 month Belgian community pharmacy-based open RCT enrolled adult patients, from March till December 2018, with registered inhaler therapy for asthma/COPD. Randomization was stratified according to the 9 community pharmacies to either receive aid for using the MyPuff-app, or a standard information leaflet to further optimize their inhaler technique at home. Inhaler technique was scored by comparing the patient demonstration with the correct protocol per device. Results: Seventy community patients (median age 64y, 56% females; 44% asthma, 39% COPD, 17% ACO) were randomized to the app (n=37; 53%) or leaflet (n=33; 47%). In 60 patients with follow-up, mean score on inhaler technique improved from 49% (SD 28%) to 65% (SD 33%) and the number of patients making critical errors dropped from 52% to 33%. Patients in the app group did not improve more than in the leaflet group. The reported use of the app (13%) was lower than the leaflet use (57%). Conclusion: The inhaler technique of asthma/COPD patients was improved 3 months after pharmaceutical care delivery, however, providing an app to further optimize inhaler technique at home was not better than providing an information leaflet.","PeriodicalId":129661,"journal":{"name":"M-health/e-health","volume":"50 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"M-health/e-health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2019.pa2235","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Despite inhalation medication being the main treatment of asthma/COPD patients, only one third of patients demonstrates a correct inhaler technique. While pharmaceutical care has shown to effectively improve inhaler technique, the integration of the MyPuff app to support continued patient education at home has not been evaluated. Aim: To investigate improvement in inhaler technique by integrating a mHealth app compared to standard information leaflets into pharmaceutical care provided to patients with asthma/COPD. Methods: This 3 month Belgian community pharmacy-based open RCT enrolled adult patients, from March till December 2018, with registered inhaler therapy for asthma/COPD. Randomization was stratified according to the 9 community pharmacies to either receive aid for using the MyPuff-app, or a standard information leaflet to further optimize their inhaler technique at home. Inhaler technique was scored by comparing the patient demonstration with the correct protocol per device. Results: Seventy community patients (median age 64y, 56% females; 44% asthma, 39% COPD, 17% ACO) were randomized to the app (n=37; 53%) or leaflet (n=33; 47%). In 60 patients with follow-up, mean score on inhaler technique improved from 49% (SD 28%) to 65% (SD 33%) and the number of patients making critical errors dropped from 52% to 33%. Patients in the app group did not improve more than in the leaflet group. The reported use of the app (13%) was lower than the leaflet use (57%). Conclusion: The inhaler technique of asthma/COPD patients was improved 3 months after pharmaceutical care delivery, however, providing an app to further optimize inhaler technique at home was not better than providing an information leaflet.
mHealth改善哮喘/COPD吸入器技术:比利时的一项随机对照试验
尽管吸入性药物治疗是哮喘/慢性阻塞性肺病患者的主要治疗方法,但只有三分之一的患者掌握了正确的吸入器技术。虽然药物治疗已经证明可以有效地改善吸入器技术,但整合MyPuff应用程序来支持患者在家中继续接受教育还没有得到评估。目的:通过将移动健康应用程序与标准信息传单相比较,研究为哮喘/慢性阻塞性肺病患者提供的药学服务中吸入器技术的改进。方法:这项为期3个月的比利时社区药房开放随机对照试验,于2018年3月至12月招募成年患者,注册吸入器治疗哮喘/COPD。根据9家社区药房进行随机分层,要么接受使用MyPuff-app的援助,要么接受标准信息传单,以进一步优化他们在家使用吸入器的技术。通过比较患者演示和每个设备的正确方案,对吸入器技术进行评分。结果:70例社区患者(中位年龄64岁,女性56%;44%哮喘,39% COPD, 17% ACO)随机分配到app (n=37;53%)或小叶(n=33;47%)。在随访的60例患者中,吸入器技术的平均评分从49% (SD 28%)提高到65% (SD 33%),发生严重错误的患者数量从52%下降到33%。应用程序组患者的改善并不比单张组多。该应用程序的使用率(13%)低于传单的使用率(57%)。结论:哮喘/慢性阻塞性肺病患者吸入器技术在药学服务提供3个月后得到改善,但在家中提供应用程序进一步优化吸入器技术并不比提供信息单张更好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信